Data / Form D filings / Penderia Technologies, Inc.
Penderia Technologies, Inc.: Form D filing
Penderia Technologies, Inc., a biotechnology company in Eugene, OR, filed a Form D with the SEC in 2024. The latest, on May 9, 2024, reports $65,000 sold of a $1 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6231 UNIVERSITY OF OREGON, Eugene, OR, 97403
- Phone
- (404) 825-2240
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2022700
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 9, 2024 | New notice | $1,000,000 | $65,000 | $935,000 | 3 | Apr 22, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Guldberg | Director | |
| Michael McGeehan | Executive Officer | |
| Keat Ghee Ong | Director, Executive Officer | |
| Kenneth Gall | Director | |
| Stephen Laffoon | Executive Officer | |
| Salil Karipott | Executive Officer |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of May 6, 2024 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Penderia Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.